| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |